Dynatronics Corp DYNT
We take great care to ensure that the data presented and summarized in this overview for DYNATRONICS CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DYNT
View allLatest Institutional Activity in DYNT
Top Purchases
Top Sells
About DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. Its orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. The company provides therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, therapeutic lasers, shortwave diathermy, radial pulse therapy, hot and cold therapy, compression therapy, and electrodes. It also offers power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, treadmills, and other related equipment. In addition, the company provides clinical supplies, including exercise bands and tubings, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Bird & Cronin, Solaris, Hausmann, Physician's Choice, and PROTEAM brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals, as well as online. It also exports its products to approximately 30 countries. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Insider Transactions at DYNT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 01
2024
|
Erin S. Enright Director |
BUY
Other acquisition or disposition
|
Indirect |
555,233
+23.57%
|
-
|
Oct 01
2024
|
Stuart Essig > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
92,810
+24.13%
|
-
|
Oct 01
2024
|
Stuart Essig > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
462,423
+23.0%
|
-
|
Oct 01
2024
|
Brian D. Baker CEO & Presidentt |
BUY
Other acquisition or disposition
|
Direct |
38,942
+22.89%
|
-
|
Oct 01
2024
|
Provco Ventures 1 LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
277,455
+22.63%
|
-
|
Aug 15
2024
|
David B Holtz Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+6.46%
|
-
|
Aug 15
2024
|
Brian Larkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+2.09%
|
-
|
Aug 15
2024
|
Andrew Hulett Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+50.0%
|
-
|
Aug 15
2024
|
Stuart Essig > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
2,000
+6.43%
|
-
|
Aug 15
2024
|
Erin S. Enright Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+6.43%
|
-
|
Aug 15
2024
|
R Scott Ward Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+7.3%
|
-
|
Jul 01
2024
|
Brian D. Baker CEO & Presidentt |
BUY
Other acquisition or disposition
|
Direct |
16,494
+15.16%
|
-
|
Jul 01
2024
|
Stuart Essig > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
39,311
+16.49%
|
-
|
Jul 01
2024
|
Stuart Essig > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
195,861
+15.29%
|
-
|
Jul 01
2024
|
Provco Ventures 1 LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
117,517
+14.9%
|
-
|
Jul 01
2024
|
Brian Larkin Director |
BUY
Other acquisition or disposition
|
Direct |
11,685
+11.32%
|
-
|
Jul 01
2024
|
Erin S. Enright Director |
BUY
Other acquisition or disposition
|
Indirect |
235,172
+15.89%
|
-
|
Apr 01
2024
|
Erin S. Enright Director |
BUY
Other acquisition or disposition
|
Indirect |
174,064
+14.71%
|
-
|
Apr 01
2024
|
Stuart Essig > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
29,096
+15.41%
|
-
|
Apr 01
2024
|
Stuart Essig > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
144,968
+14.01%
|
-
|
Last 12 Months Summary
Other acquisition or disposition | 2.86M shares |
---|---|
Grant, award, or other acquisition | 26K shares |